TY  - GEN
AU  - Mita,Alain C
AU  - Takimoto,Chris H
AU  - Mita,Monica
AU  - Tolcher,Anthony
AU  - Sankhala,Kamalesh
AU  - Sarantopoulos,John
AU  - Valdivieso,Manuel
AU  - Wood,Leslie
AU  - Rasmussen,Erik
AU  - Sun,Yu-Nien
AU  - Zhong,Z Don
AU  - Bass,Michael B
AU  - Le,NgocDiep
AU  - LoRusso,Patricia
TI  - Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors
SN  - 1557-3265
PY  - 2010///0812
KW  - Adult
KW  - Angiopoietin-1
KW  - antagonists & inhibitors
KW  - Angiopoietin-2
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Drug Administration Schedule
KW  - Drugs, Investigational
KW  - administration & dosage
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Recombinant Fusion Proteins
KW  - Recombinant Proteins
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-09-3368
ER  -